EUVIMEDEUVIMED entdecken
Übersichtsarbeit

DNA nanotechnology-based strategies for minimising hybridisation-dependent off-target effects in oligonucleotide therapies

Xiaoyu Li, Huanhuan Hu, Hailong Wang, Jia Liu, Wenting Jiang, Feng Zhou, Jiantao Zhang iD

Materials Horizons · 2025 · 12 (5) · 1388-1412

DOI: 10.1039/d4mh01158a ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Materials Horizons, 2025. Verfasst von Xiaoyu Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Advanced Theranostic Materials and Technology, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, N…. Hauptthemen laut MEDLINE: Oligonucleotides, Nanotechnology, Genetic Therapy, DNA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 291 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oligonucleotide-based targeted therapy has emerged as a breakthrough in medicine, offering treatments for various diseases. We review the hybridisation-dependent off-target effects of therapeutic oligonucleotides, and the DNA nanotechnology-based strategies designed to mitigate these interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OligonucleotidesNanotechnologyGenetic TherapyDNAHumansAnimalsOligonucleotides, AntisenseNucleic Acid HybridizationCRISPR-Cas Systems

Substanzen

OligonucleotidesDNAOligonucleotides, Antisense

Autor:innen und Institutionen

  • Laboratory of Advanced Theranostic Materials and Technology, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, China. zhangjiantao@nimte.ac.cn.
  • Ningbo Cixi Institute of Biomedical Engineering, Ningbo, China.
  • School of Materials Science and Chemical Engineering, Ningbo University, Ningbo, China.
  • Cixi Biomedical Research Institute, Wenzhou Medical University, Zhejiang, China.

ORCID-Profile: Jiantao Zhang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Li, X., Hu, H., Wang, H., Liu, J., Jiang, W., Zhou, F., & Zhang, J. (2025). DNA nanotechnology-based strategies for minimising hybridisation-dependent off-target effects in oligonucleotide therapies. Materials Horizons, 12(5), 1388-1412. https://doi.org/10.1039/d4mh01158a

Vancouver

Li X, Hu H, Wang H, Liu J, Jiang W, Zhou F, et al. DNA nanotechnology-based strategies for minimising hybridisation-dependent off-target effects in oligonucleotide therapies. Materials Horizons. 2025;12(5):1388-1412. doi:10.1039/d4mh01158a

BibTeX
@article{Li2025,
  author = {Li, Xiaoyu and Hu, Huanhuan and Wang, Hailong and Liu, Jia and Jiang, Wenting and Zhou, Feng and Zhang, Jiantao},
  title = {DNA nanotechnology-based strategies for minimising hybridisation-dependent off-target effects in oligonucleotide therapies},
  journal = {Materials Horizons},
  year = {2025},
  volume = {12},
  number = {5},
  pages = {1388--1412},
  doi = {10.1039/d4mh01158a}
}
Kostenlos starten →